The Capital Group Companies, Inc. reduced its holding of INNOVENT BIO (01801) by approximately 3,327,400 shares at a price of around HK$31.55 per share.
On January 20th, The Capital Group Companies, Inc. reduced its holdings in Sino Biopharmaceutical (01801) by 3,327,405 shares, priced at 31.5469 Hong Kong dollars per share, for a total amount of approximately 105 million Hong Kong dollars.
According to the latest data from the Hong Kong Stock Exchange, on January 20, The Capital Group Companies, Inc. reduced its holdings of INNOVENT BIO (01801) by 3,327,405 shares, at a price of 31.5469 Hong Kong dollars per share, with a total amount of approximately 105 million Hong Kong dollars. After the reduction, the latest number of shares held is approximately 96,778,400 shares, with a shareholding proportion of 5.91%.
RECOMMEND
Anti-Overcompetition Drive Takes Hold Across Multiple Chinese Industries
04/07/2025
Bank of England Governor: Rise of Stablecoins May Undermine Confidence in National Currencies
04/07/2025
What the Passage of the “Big and Beautiful Act” Means for Americans: Gains and Losses Across Demographics
04/07/2025
